Insider selling at Cryoport, Inc. over the past year, especially in recent months, may worry shareholders. However, significant insider ownership indicates alignment with other shareholders. The absence of insider buying in the last three months is noteworthy.
Cryoport股票讨论
VGXI选择Cryoport提供生物储存、生物服务和供应链解决方案,以推进下一代疗法
Cryoport公司(纳斯达克:CYRX)和VGXI公司宣布建立战略合作伙伴关系,支持生物制药公司开发细胞和基因疗法以及mRNA治疗。合作将于2024年10月开始,Cryoport系统将从位于得克萨斯州休斯敦的设施为VGXI在伍兹兰和康罗得克萨斯州设施制造的质粒DNA产品提供生物储存和生物服务。
暂无评论